| 名稱(chēng) | β-thalassemia mutation Reference Standard Ⅸ |
| 型號(hào) | CBPD0009 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | β-thalassemia mutation Reference Standard Ⅸ |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 新品發(fā)布【地中海貧血標(biāo)準(zhǔn)品】
- 增強(qiáng)腫瘤免疫療法新靶點(diǎn)：ADORA2B（腺苷A2B受體）
- 細(xì)胞株有關(guān)細(xì)胞培養(yǎng)污染的控制
- 可視化觀察黑色素瘤早期轉(zhuǎn)移，鑒定出一種新的治療靶標(biāo)
- 細(xì)胞株培養(yǎng)傳代時(shí)的指數(shù)增生期解讀
- 聚焦靶點(diǎn)BRAF——BRAF相關(guān)突變細(xì)胞強(qiáng)勢(shì)登場(chǎng)
- LTβR信號(hào)通路誘導(dǎo)三級(jí)淋巴結(jié)構(gòu)的形成，促進(jìn)趨化因子的表達(dá)
- Western Blot標(biāo)準(zhǔn)操作流程
- atcc細(xì)胞培養(yǎng)紫外燈照射的目的與實(shí)踐
- 川大華西CRISPR研究再獲新進(jìn)展
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > 地中海貧血標(biāo)準(zhǔn)品 > CBPD0009β-thalassemia mutation Reference Standard Ⅸ
- 詳細(xì)內(nèi)容
| Introduction | |
| Format | Genomic DNA |
| Description | β-thalassemia (β-mediterraneananemia) refers to the A group of hemoglobinopathies in which synthesis is partially or completely inhibited. |
| Technical Data | |
| Mutation 1 | Variation site: IVS-I-1(G>A) |
| DNA Change: c.92+1G>A | |
| Zygosity: Heterozygous | |
| Allelic Frequency: 50% | |
| Chr position(GRCh37): Chr11:5248159C>T | |
| Transcript: NM_000518.5 | |
| Mutation 2 | Variation site: IVS-I-6(T>C) |
| DNA Change: c.92+6T>C | |
| Zygosity: Heterozygous | |
| Allelic Frequency: 50% | |
| Chr position(GRCh37): Chr11:5248154A>G | |
| Transcript: NM_000518.5 | |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
Sanger sequencing |
Figure 1. IVS-I-1(G>A) Heterozygous
|
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)